Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results

Autor: PENGO, V. ^*, CRIPPA, L., FALANGA, A., FINAZZI, G., MARONGIU, F., MOIA, M., PALARETI, G., POLI, D., TESTA, S., TIRAFERRI, E., TOSETTO, A., TRIPODI, A., SIRAGUSA, S., MANOTTI, C.

Publikováno v: In Journal of Thrombosis and Haemostasis October 2012 10(10):1979-1987

The prothrombin time/international normalized ratio (PT/INR) Line: derivation of local INR with commercial thromboplastins and coagulometers – two independent studies

Autor: POLLER L, IBRAHIM S, KEOWN M, PATTISON A, JESPERSEN J, EUROPEAN ACTION ON A.N.T.I.C.O.A.G.U.L.A.T.I.O.N. COLLABORATORS: MARUN S, MUNTEAN W, ASPÖCK G, BAILLEUL E, WIJNS W, MICHEL T, JOCHMANS K, CHATELAIN B, MARCELIS L, NIJS AN, JOHNSTON M, KYNDE K, SYRÄJLÄ M, SAVOLAINEN ER, IVASKA K, RAJAMÄKI A, VANHARANTA R, JUHAN I, AILLAUD MF, GUILLIN MC, HUISSE MG, SIE P, LECOMPTE T, SCHMITT Y, HARENBERG J, PLESCH W, ARONIS S, THEODOSSIADES G, TSOUKANAS B, MARKALA D, DITSA M, CAHILL M, MADDEN M, FITZGERALD H, MCCARTHY D, COLLINS B, ROONEY S, NAPARSTEK E, MARONGIU F, ERBA N, TESTA S, MARIANI G, POTÌ R, MANNUCCI PM, TRIPODI A, BADER R, PENGO V, GRESELE P, D'INCÀ M, AGENO W, TOSETTO A, HENSGENS HE, IDEMA RN, OOSTERHOUT DH, MULDER AB, HAMULYAK K, VD DUSSEN H, MUSIAL J, GAGO T, PALMEIRO A, CAMPOS M, MARQUES DIAS DA, CUNHA MONTEIRO Á, ANGELA CUNHA M, DE GAIA WN, PETERNEL P, STEGNAR M, FONTCUBERTA J, BORRELL M, REVERTER JC, SANTASUSANA PD, LOPEZ FERNANDEZ MF, MONTERO J, RIBERA CASADO C, VICENTE V, EDLUND B, EGBERG N, LÄMMLE B, ALBERIO L, DE MOERLOOSE P, REBER G, MACHIN SJ, MACKIE I, LAWRIE A, LUCKIT J, SHANKS D, DOLAN G, FLAHERTY T, LUDLAM CA, WALKER ID, LAWSON DE, TRISCOTT M, MARLAR RA, HEIT JA, WATZKE H, WEISSER B, GALLUS AS, OSMOND J, CORNET I, MUNSTER AM, LEED B, CHILLOU C, DEFARD M, HORELLOU MH, HALKIN H, LOEBSTEIN R, KIRGNER I, DENTALI F, TRAPANI LOMBARDO V, SOTTILOTTA G, CONSIGLIO P, DE MICHELE S, MOIA M, CARPENEDO M, OLIVIERO B, MANOTTI C, TASSONI MI, PALARETI G, BRUSI C, LEGNANI C, PEGORARO C, ANDRIANI C, GRAZIA CIRIGLIANO M, RIBALDI E, ABBATE R, POLI D, PERRICONE C, SCHIAVULI M, CASIERA C, LUPONE MR, ROSSI E, CRIVELLI S, BIROLINI A, PARENTE F, MIGLIETTA AM, CAMPOBASSO M, SYDOR W, KREVEL B, FERNANDEZ MA, LOZANO M, SHIACH C, BOWYER C, CHARLES F., PALARETI, GUALTIERO, COSMI, BENILDE

Publikováno v: European Action on Anticoagulation (EAA) & Münster, A-M B 2011, ' The prothrombin time/international normalised ratio (PT/INR) line: derivation of local INR with commercial thromboplastins and coagulometers – two independent studies ', Journal of Thrombosis and Haemostasis, vol. 9, no. 1, pp. 140-148 . https://doi.org/10.1111/j.1538-7836.2010.04109.x
Journal of Thrombosis and Haemostasis, 9(1), 140-148. Wiley

The WHO scheme for prothrombin time (PT) standardization has been limited in application, because of its difficulties in implementation, particularly the need for mandatory manual PT testing and for local provision of thromboplastin international ref

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4033b274d27f3fdad18dfdd3b426609a
https://doi.org/10.1111/j.1538-7836.2010.04109.x

Identification and role of the hemostasis and thrombosis expert in the National Health System

Autor: Rodeghiero F, Morfini M, Nozzoli C, Manotti C, Violi F, Biasioli B, Velati C., CASTALDO, GIUSEPPE, PANE, FABRIZIO

Hemorrhagic and thrombotic diseases are very heterogeneous disorders that may affect a relevant part of the population, as in the case of patients taking antithrombotic drugs. The appropriate management of such conditions requires the availability of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3730::690a808c8ebbdf20b3353572964e2b2a
http://hdl.handle.net/11588/592274

Managing anticoagulation in the COVID-19 era between lockdown and reopening phases.

Autor: Poli D; Dipartimento Cardiotoracovascolare, Centro Trombosi, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy. polida@aou-careggi.toscana.it., Tosetto A; UOS Centro Malattie Emorragiche e Trombotiche - Divisione di Ematologia, Ospedale S. Bortolo, Vicenza, Italy., Palareti G; Fondazione Arianna Anticoagulazione, Bologna, Italy., Barcellona D; Dipartimento di Scienze Mediche e Sanità Pubblica, Università di Cagliari, Cagliari, Italy., Ciampa A; Centro Emostasi, AORN S.G. Moscati, Avellino, Italy., Grandone E; Thrombosis and Haemostasis Unit, Fondazione IRCCS 'Casa Sollievo della Sofferenza', San Giovanni Rotondo, Italy.; Ob/Gyn Department of The First I.M. Sechenov Moscow State Medical University, Moscow, Russia., Manotti C; Centro Emostasi, Medicina Interna ad indirizzo angiologico e coagulativo, Dipartimento di Medicina Interna e Specialistica, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy., Moia M; IRCCS MultiMedica Group, Milan, Italy., Squizzato A; Department of Medicine and Surgery, Research Centre on Thromboembolic Diseases and Antithrombotic Therapies, University of Insubria, Varese and Como, Italy., Toschi V; Department of Hematology and Blood Transfusion, ASST Santi Paolo e Carlo, Milan, Italy., Testa S; Centro Emostasi e Trombosi, Ospedale di Cremona, Cremona, Italy.

Publikováno v: Internal and emergency medicine [Intern Emerg Med] 2020 Aug; Vol. 15 (5), pp. 783-786. Date of Electronic Publication: 2020 Jun 08.

ISAM: international study on anticoagulation management. The Italian experience

Autor: PENGO V, ADRIANI C, ALATRI A, ANTONUCCI E, BAUDO F, CAIMI TM, CAULI C, LOPATRIELLO S, MANOTTI C, MARONGIU F, NEGRINI C, POLI D, TASSONI MI, TESTA S, ATTIN G., MALATO, Alessandra, SIRAGUSA, Sergio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3658::aaec7cb0c054326340b992dc441f4c56
http://hdl.handle.net/10447/4287